User Information - Halyard On-Q Pump Mode D'emploi

ON-Q* Pump with ONDEMAND* Bolus Button
e
Instructions For Use
IMPORTANT INFORMATION
Please read the entire document before operating the
ON-Q* device. Follow all instructions carefully to ensure
the safety of patient and/or user.

USER INFORMATION

• For 24-hour Product Support, call 800-444-2728 or
+1-949-206-2700 (English only).
• Visit www.iflo.com or contact your sales representative
for the latest product information and Technical Bulletins,
including but not limited to:
• Use of ON-Q* Pump in Magnetic Resonance (MR)
environment
• Latex Sensitivity
• Continuous Infusion in Pediatric Patients
• Use of ON-Q* Pump in Hand and Foot Surgery
Volume and Flow Rate Selection
• What We Know About Chondrolysis Today
• Perioperative Autologous Blood Transfusions
• USP 797
• Effect of Storage Times on Flow Rate on Pre-filled
ON-Q* Elastomeric Pumps
• Patient Guidelines
WARNING
Bolus is deliverable on demand. To reduce potential adverse
effects, medication dosing should be based on the Total Flow
Rate.
• Total Flow Rate refers to bolus + basal rate. To reduce
potential adverse effects, medication dosing should be
based on the Total Flow Rate.
• Due to risk of ischemic injury, vasoconstrictors such
as epinephrine are not recommended for continuous
infusions for the following routes of administration:
intraoperative site, perineural and percutaneous
(excluding epidural).
• Medications or fluids must be administered per
instructions provided by the drug manufacturer. Physician
is responsible for prescribing drug based on each patient's
clinical status (such as age, body weight, disease state of
patient, concomitant medications, etc.).
• There is no alarm or alert when flow interruption occurs,
therefore, life-supporting medications whose usage
may cause serious injury or death due to stoppage or
under-delivery are not recommended for infusion with
the ON-Q* device.
• There is no indicator of pump infusion status, therefore,
use caution where over-delivery of medications could
result in serious injury or death.
• Epidural infusion of analgesics is limited to uses of
indwelling catheters specifically designed for epidural
delivery. To prevent infusion of drugs not indicated
for epidural use, do not use IV set with additive ports.
It is strongly recommended that devices used for
administration of medication via epidural routes be clearly
differentiated from all other infusion devices.
• To avoid complications, use the lowest flow rate, volume
and drug concentration required to produce the desired
result. In particular:
• Avoid placing the catheter in the distal end of
extremities (such as fingers, toes, nose, ears, penis,
etc.) where fluid may build up as this may lead to
ischemic injury or necrosis.
• Avoid placing the catheter in joint spaces. Although
there is no definitive established causal relationship,
some literature has shown a possible association
between continuous intra-articular infusions
(particularly with bupivacaine) and the subsequent
development of chondrolysis.
• Avoid tight wrappings which can limit blood supply or
fluid diffusion.
• To prevent continuous over-delivery of medication
significantly greater than the Total Flow Rate, close the clamp
if any of the following conditions occur:
• The red tab is not removed or breaks while removing.
• The orange bolus refill indicator is not near the top at all times
except within 60 minutes of pressing the bolus button.
• The bolus button will not latch except within
30 minutes of pressing the bolus button.
If the bolus button does not pop back up within 30 minutes of
pressing it, check position of orange indicator:
• If orange indicator is in the bottom position, close
the clamp. Continuous medication delivery may be
occurring significantly greater than the Total Flow Rate.
• If orange indicator is in the top position: something
may be impeding the flow. Check for tubing kinks,
closed clamp or patency of connected devices such as
catheter or unvented filter (verify patency) according
to your standard protocol.
3